BioNTech SE
@BioNTech_Group
Today, together with OncoC4, we announced data on an investigational selective Treg modulator candidate in patients with advanced sqNSCLC.
Learn more in our press release: bit.ly/4oGMM9U
#LungCancer #NACLC25
Learn more in our press release: bit.ly/4oGMM9U
#LungCancer #NACLC25
0 24